Shares & Derivatives
Hyphens Pharma: 5 Things I like about the company (Guest Post)
By InvestingNote  •  May 21, 2020

Hyphens Pharma recently announced its 1st quarter 2020 results ended 31 March 2020.

This post was originally posted here. The writer, James Yeo is a veteran community member and blogger on InvestingNote, with username known as Smallcapasia and has 853 followers. I have to say that its results are pretty impressive. Compared to the previous year, 1Q 2020 revenue came in at 16.1% higher to $31.4 mil and net profits surged 48.6% to $2.12 mil. Dividends were also hiked up to $0.01 from $0.0055 last year, which translates to a 4% dividend yield based on its share price of $0.25. There are much more things to cover but let’s check out the company’s profile first.

About Hyphens Pharma

For a quick background, Hyphens Pharma International Limited (SGX: 1J5) is Singapore’s leading specialty pharmaceutical and consumer healthcare group. With a long history dating back to 1998, Hyphens has a direct presence in 5 ASEAN countries – Singapore (HQ), Indonesia, Malaysia, the...
Read the full article
By InvestingNote
InvestingNote is Singapore’s first & largest community-driven platform where investors and traders from all levels connect and share ideas with one another.
LEAVE A COMMENT
LEAVE A COMMENT

Your email address will not be published.

*

Your Email Address will not be published
*

Read More Articles
More from thefinance